EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Prevalence and outcomes of primary hyperparathyroidism in sarcoidosis patients: a large-scale retrospective cohort study

Abdulrahman Ghaleb iD, Ahmed Abdelmaksoud, Yaser Bashumeel iD, Mahmoud Abdalnaeem, Anas Alselek, Salem I Noureldine, Emad Kandil

The Journal of Clinical Endocrinology & Metabolism · 28.07.2026

DOI: 10.1210/clinem/dgag302 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.07.2026. Verfasst von Abdulrahman Ghaleb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hypercalcemia in sarcoidosis is classically attributed to granuloma-mediated calcitriol excess, but primary hyperparathyroidism (PHPT)—the most common cause of ambulatory hypercalcemia—frequently coexists. These 2 etiologies are mechanistically distinct: sarcoid hypercalcemia is suppressed-PTH and 1,25(OH)2D-driven, while PHPT is autonomous-PTH-driven and surgically curable. Because both can independently sustain hypercalcemia, attribution to sarcoidosis alone risks anchoring bias and delayed identification of PHPT.

Objective

To determine PHPT prevalence in sarcoidosis, characterize hypercalcemia-evaluation adequacy, and assess parathyroidectomy (PTX) impact on all-cause mortality.

Design

Retrospective cohort study.

Setting

TriNetX US Collaborative Network, federated electronic health record data from >120 million patients. Patients 117 395 adults with ICD-10 sarcoidosis (D86) and ≥1 serum calcium measurement.

Interventions

None (observational). Main outcome measures Intact parathyroid hormone (iPTH) assessment rate; biochemical and coded PHPT prevalence; PTX utilization and outcomes; all-cause mortality.

Results

Hypercalcemia: 31.3% (n = 36 790); only 30.5% received iPTH. Biochemical PHPT: 3.0% (n = 3493)—of whom 75.4% (n = 2633) had no ICD-10 code. PTX in coded PHPT: 36.6% (n = 315), with 74.6% biochemical cure. Hypercalcemia hazard ratio (HR) 1.33 (1.29-1.38), coded PHPT HR 1.50 (1.40-1.60), no-PTX HR 4.2 (2.7-6.4); all P < .001.

Conclusion

PHPT is prevalent, profoundly under-evaluated, and under-treated in sarcoidosis. Routine iPTH measurement and timely surgical referral are essential.

Schlagwörter

Stichwörter der Autor:innen

hypercalcemiamortalityparathyroidectomyprimary hyperparathyroidismreal-world evidencesarcoidosis

Autor:innen und Institutionen

  • Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
  • University of California, Riverside, Riverside, California, USA.
  • Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Department of Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

ORCID-Profile: Abdulrahman Ghaleb, Yaser Bashumeel

Zitieren

APA

Ghaleb, A., Abdelmaksoud, A., Bashumeel, Y., Abdalnaeem, M., Alselek, A., Noureldine, S. I., & Kandil, E. (2026). Prevalence and outcomes of primary hyperparathyroidism in sarcoidosis patients: a large-scale retrospective cohort study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag302

Vancouver

Ghaleb A, Abdelmaksoud A, Bashumeel Y, Abdalnaeem M, Alselek A, Noureldine SI, et al. Prevalence and outcomes of primary hyperparathyroidism in sarcoidosis patients: a large-scale retrospective cohort study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag302

BibTeX
@article{Ghaleb2026,
  author = {Ghaleb, Abdulrahman and Abdelmaksoud, Ahmed and Bashumeel, Yaser and Abdalnaeem, Mahmoud and Alselek, Anas and Noureldine, Salem I and Kandil, Emad},
  title = {Prevalence and outcomes of primary hyperparathyroidism in sarcoidosis patients: a large-scale retrospective cohort study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag302}
}
Kostenlos starten →